Browse > Article

The Change of IgG Antibody Titer to Measles, Mumps and Rubella According to Age  

Pang, Sung Joon (Department of Pediatrics, Kwandong University College of Medicine)
Choi, Kyong Min (Department of Pediatrics, Kwandong University College of Medicine)
Publication Information
Pediatric Infection and Vaccine / v.18, no.2, 2011 , pp. 117-123 More about this Journal
Abstract
Purpose : We investigated the change of antibody titer to measles, mumps and rubella according to age after vaccination. Methods : The IgG antibody titers to measles, mumps and rubella were tested on the residual serum from patients aged 7-20 years old after routine laboratory testing in the hospital with informed consent from the parents. Results : Antibody to measles was present in 275 cases out of 408 cases with a positive rate of 67.4%, the mean IgG titer was 2.77${\pm}$1.18 Index. Antibody to mumps was present in 112 cases out of 408 cases with a positive rate of 27.5%, the mean IgG titer was 2.08${\pm}$1.29 Index. Antibody to rubella was present in 367 cases out of 408 cases with a positive rate of 90.0%, the mean IgG titer was 60.46${\pm}$63.47 IU/mL. Conclusion : It is important to maintain a high rate of vaccination coverage in order to prevent an outbreak of measles, mumps, or rubella. It is also important to stress the maintenance of vaccination records for further reference.
Keywords
Measles; Mump; Rubella; IgG antibody;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Global measles mortality, 2000-2008. MMWR Morb Mortal Wkly Rep 2009;58:1321-6.
2 Cohen C, White JM, Savage EJ, Glynn JR, Choi Y, Andrews N, et al. Vaccine effectiveness estimates, 2004-2005 mumps outbreak, England. Emerg Infect Dis 2007;13:12-7.
3 Atrasheuskaya AV, Blatun EM, Kulak MV, Atrasheuskaya A, Karpov IA, Rubin S, et al. Investigation of mumps vaccine failures in Minsk, Belarus, 2001-2003. Vaccine 2007;25:4651-8.   DOI   ScienceOn
4 Peltola H, Kulkarni PS, Kapre SV, Paunio M, Jadhav SS, Dhere RM. Mumps outbreaks in Canada and the United States: time for new thinking on mumps vaccines. Clin Infect Dis 2007;45:459-66.   DOI   ScienceOn
5 Bloch AB, Orenstein WA, Ewing WM, Spain WH, Mallison GF, Herrmann KL, et al. Measles outbreak in a pediatric practice: airborne transmission in an office setting. Pediatrics 1985;75:676-83.
6 Riley EC, Murphy G, Riley RL. Airborne spread of measles in a suburban elementary school. Am J Epidemiol 1978;107:421-32.   DOI
7 Bellanti JA, Sanga RL, Klutinis B, Brandt B, Artenstein MS. Antibody responses in serum and nasal secretions of children immunized with inactivated and attenuated measles-virus vaccines. N Engl J Med 1969;280:628-33.   DOI   ScienceOn
8 Krugman S, Giles JP, Friedman H, Stone S. Studies on immunity to measles. J Pediatr 1965;66:471-88.   DOI
9 Krause PJ, Cherry JD, Carney JM, Naiditch MJ, O'Connor K. Measles-specific lymphocyte reactivity and serum antibody in subjects with different measles histories. Am J Dis Child 1980;134:567-71.
10 Gallagher MR, Welliver R, Yamanaka T, Eisenberg B, Sun M, Ogra PL. Cell-mediated immune responsiveness to measles. Its occurrence as a result of naturally acquired or vaccine-induced infection and in infants of immune mothers. Am J Dis Child 1981;135:48-51.   DOI
11 Pedersen IR, Mordhorst CH, Ewald T, von Magnus H. Long-term antibody response after measles vaccination in an isolated arctic society in Greenland. Vaccine 1986;4:173-8.   DOI   ScienceOn
12 Parker AA, Staggs W, Dayan GH, Ortega-Sanchez IR, Rota PA, Lowe L, et al. Implications of a 2005 measles outbreak in Indiana for sustained elimination of measles in the United States. N Engl J Med 2006;355:447-55.   DOI   ScienceOn
13 Erdman DD, Heath JL, Watson JC, Markowitz LE, Bellini WJ. Immunoglobulin M antibody response to measles virus following primary and secondary vaccination and natural virus infection. J Med Virol 1993;41:44-8.   DOI   ScienceOn
14 Yoo JW, Sohn HE, Chung NE, Choi TY. Age related measles antibody levels after vaccination. Korean J Clin Pathol 1999;19:227-33.
15 Shin YK, Yoon JK, Choung JT, Tockgo YC. Changes of measles specific IgG after active immunization of measles in Korean children. Korean Journal of Pediatrics 1996;39:788-96.
16 Hethcote HW. Measles and rubella in the United States. Am J Epidemiol 1983;117:2-13.   DOI
17 King GE, Markowitz LE, Patriarca PA, Dales LG. Clinical efficacy of measles vaccine during the 1990 measles epidemic. Pediatr Infect Dis J 1991;10:883-8.   DOI
18 Watson JC, Pearson JA, Markowitz LE, Baughman AL, Erdman DD, Bellini WJ, et al. An evaluation of measles revaccination among school-entry-aged children. Pediatrics 1996;97:613-8.
19 Ramsay ME, Jin L, White J, Litton P, Cohen B, Brown D. The elimination of indigenous measles transmission in England and Wales. J Infect Dis 2003;187 (Suppl 1):S198-207.   DOI
20 Measles--United States, 1996, and the interruption of indigenous transmission. MMWR Morb Mortal Wkly Rep 1997;46:242-6.
21 Galazka AM, Robertson SE, Kraigher A. Mumps and mumps vaccine: a global review. Bull World Health Organ 1999;77:3-14.
22 Oh SH, Yum DH, Kang JH, Sohn YM, Lee HJ, Pyun BY, et al. Distribution of Anti-Mumps IgM Antibody in Children Presumptively Diagnosed of Mumps. Korean Journal of Pediatrics 2001;44:17-24.
23 Peltola H, Davidkin I, Paunio M, Valle M, Leinikki P, Heinonen OP. Mumps and rubella eliminated from Finland. JAMA 2000;284:2643-7.   DOI   ScienceOn
24 Na BK, Go UY, Lee JY, Lee JS, Shin GC, Lee JY, et al. Seroepidemiology of mumps IgG antibody on primary school children in Kyonggi province, 1996 and 1999. Korean Journal of Infectious Diseases 2001;33:157-64.   DOI   ScienceOn
25 Shin YK, Cheon HW, Lee KH, Choung JT, Tockgo YC. Mumps and rubella-specific IgG levels of term pregnant women and their neonates. Korean Journal of Pediatrics 1998;41:47-52.
26 Park YB, Jung EG, Moon KR. A measurement of mumps specific IgG & IgM antibody in the sera of mumps vaccinated healthy children. Korean Journal of Pediatrics 1996;39:491-6.
27 Miller E, Hill A, Morgan-Capner P, Forsey T, Rush M. Antibodies to measles, mumps and rubella in UK children 4 years after vaccination with different MMR vaccines. Vaccine 1995;13:799-802.   DOI   ScienceOn
28 Boulianne N, De Serres G, Ratnam S, Ward BJ, Joly JR, Duval B. Measles, mumps, and rubella antibodies in children 5-6 years after immunization: effect of vaccine type and age at vaccination. Vaccine 1995;13:1611-6.   DOI   ScienceOn
29 Johnson CE, Kumar ML, Whitwell JK, Staehle BO, Rome LP, Dinakar C, et al. Antibody persistence after primary measles-mumps-rubella vaccine and response to a second dose given at four to six vs. eleven to thirteen years. Pediatr Infect Dis J 1996;15:687-92.   DOI   ScienceOn
30 Lee SJ, Kim CH. Prevalence of Rubella Antibodies and Preventive Measures of Congenital Rubella Syndrome in Korea. Korean Journal of Pediatrics 1996;39:151-65.